Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

CT1812 slowed cognitive decline by 95% in Alzheimer’s disease patients with lower levels of plasma p-tau217 in a pre-specified analysis from ...

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today ...

Ted Turner's colorful life is chronicled over six episodes on Max in a docuseries dubbed "Call Me Ted" out Nov. 13, 2024.

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

This article is part of “Dealing the Dead,” a series investigating the use of unclaimed bodies for medical research. A Texas county that for years gave unclaimed bodies to a local medical ...

Oct. 8, 2024 — Scientists have recreated the growth of Lewy bodies in human neurons and followed their formation to gain important insight into why and how they form. Critically, they find that ...

We look forward to reading out the results of our study later this year.” Dementia with Lewy bodies is the second most common form of dementia, affecting an estimated 1.4 million Americans. The ...

Material produced by public bodies which have Crown status is subject to Crown copyright protection under Section 163 of the Copyright Designs and Patents Act 1988 ...

Lewy body dementia is the second most common cause of neurodegenerative dementia. According to Dementia UK, Lewy body dementia accounts for about 10-15% of dementia cases, which means that about ...